1. Home
  2. AMLX vs DIN Comparison

AMLX vs DIN Comparison

Compare AMLX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMLX
  • DIN
  • Stock Information
  • Founded
  • AMLX 2014
  • DIN 1958
  • Country
  • AMLX United States
  • DIN United States
  • Employees
  • AMLX N/A
  • DIN N/A
  • Industry
  • AMLX Biotechnology: Pharmaceutical Preparations
  • DIN Restaurants
  • Sector
  • AMLX Health Care
  • DIN Consumer Discretionary
  • Exchange
  • AMLX Nasdaq
  • DIN Nasdaq
  • Market Cap
  • AMLX 459.1M
  • DIN 379.1M
  • IPO Year
  • AMLX 2022
  • DIN 1991
  • Fundamental
  • Price
  • AMLX $8.41
  • DIN $24.20
  • Analyst Decision
  • AMLX Strong Buy
  • DIN Hold
  • Analyst Count
  • AMLX 8
  • DIN 8
  • Target Price
  • AMLX $11.00
  • DIN $26.33
  • AVG Volume (30 Days)
  • AMLX 2.2M
  • DIN 411.4K
  • Earning Date
  • AMLX 08-07-2025
  • DIN 08-06-2025
  • Dividend Yield
  • AMLX N/A
  • DIN 8.47%
  • EPS Growth
  • AMLX N/A
  • DIN N/A
  • EPS
  • AMLX N/A
  • DIN 3.61
  • Revenue
  • AMLX N/A
  • DIN $820,851,000.00
  • Revenue This Year
  • AMLX N/A
  • DIN $8.51
  • Revenue Next Year
  • AMLX N/A
  • DIN $1.83
  • P/E Ratio
  • AMLX N/A
  • DIN $6.66
  • Revenue Growth
  • AMLX N/A
  • DIN N/A
  • 52 Week Low
  • AMLX $1.76
  • DIN $18.63
  • 52 Week High
  • AMLX $8.45
  • DIN $37.44
  • Technical
  • Relative Strength Index (RSI)
  • AMLX 80.57
  • DIN 42.33
  • Support Level
  • AMLX $5.97
  • DIN $25.06
  • Resistance Level
  • AMLX $6.86
  • DIN $27.24
  • Average True Range (ATR)
  • AMLX 0.57
  • DIN 1.15
  • MACD
  • AMLX 0.17
  • DIN -0.29
  • Stochastic Oscillator
  • AMLX 98.26
  • DIN 5.85

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

Share on Social Networks: